NIH Deputy Director to Discuss Challenges to Biomedical Research in U.S.
Scientific progress is moving faster than ever in the United States, yet scientific innovation faces its greatest threat ever due to across-the-board spending cuts.
Sally Rockey at UCSF
“NIH: Interesting Times, Challenging Times”
Tuesday, Sept. 24
9-10 a.m.
Byers Auditorium, Genentech Hall
Mission Bay campus
To attend the lecture, please RSVP to [email protected]. Space is limited.
Sally Rockey, PhD, deputy director for Extramural Research at the National Institutes of Health, will address this painful paradox in her talk at UC San Francisco on Tuesday, Sept. 24, titled “NIH: Interesting Times, Challenging Times.”
Ensuring the future of U.S competitiveness and innovation in biomedical research is of the upmost importance to NIH. One avenue for achieving this goal is to support a sustainable and diverse workforce.
Rockey co-chaired the NIH Advisory Committee to the Director on the Biomedical Research Workforce, which developed a workforce model to inform decisions about training the right number of people for the relevant positions that will advance science and promote health. She’ll provide an implementation update on the Workforce Committee’s recommendations during her talk.
As head of extramural research, Rockey focuses on policies and guidelines for administering research grants in partnership with the biomedical research community. Extramural grants represent more than 80 percent of the $31.2 billion NIH budget. These are awarded to investigators throughout the U.S. and abroad.
About the NIH Office of Extramural Research
Through its approximately 1,200 individuals and $112 million budget, the Office of Extramural Research (OER) provides the infrastructure that makes these grants happen. OER provides the corporate framework for NIH research administration, ensuring scientific integrity, public accountability and effective stewardship of the NIH research grant portfolio with the ultimate goal of preserving public trust in research. OER serves as a vital interface between the NIH and the biomedical research community by guiding investigators through the process of attaining grants funding and helping them understand and navigate through federal policies and procedures.